anti-Influenza A (matrix protein) antibody product blog
Tags: Antibody; Monoclonal Antibody; Influenza A (matrix protein); anti-Influenza A (matrix protein) antibody;
The Influenza A (matrix protein) n/a (Catalog #MBS312361) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Influenza A (matrix protein) can be used in a range of immunoassay formats including, but not limited to, Optimal dilutions/concentrations should be determined by the end user.Applications not yet tested. . Researchers should empirically determine the suitability of the Influenza A (matrix protein) n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
MAb to Influenza A (Matrix)
Monoclonal Antibody to Influenza A (Matrix).
Immunogen: Influenza A Virus A/Puerto Rico/8/34 (H1N1) and A/Bangkok/1/79 (H3N2) virus
Source: Culture
Affinity Constant: Not determined. Preservative: 15mM Sodium azide
Important Note: Centrifuge before opening to ensure complete recovery of vial contents.
Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0 %. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Influenza A (matrix protein) are readily searchable from our website. Different antibodies against the same target such as Influenza A (matrix protein) may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.